Suppr超能文献

药剂师远程医疗共同管理对心力衰竭的影响:一项非随机对照研究。

Impact of Pharmacist Telehealth Comanagement for Heart Failure: A Nonrandomized Controlled Study.

作者信息

Fox D Steven, Zawadski Nadine, Buss Kimberly, Leahy Angela, Zhang Q Laura, Chan Yu Christine

机构信息

USC Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences, Los Angeles, California, USA.

USC Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences, Los Angeles, California, USA; FTI Center for Healthcare Economics and Policy, Los Angeles, California, USA.

出版信息

JACC Adv. 2025 Jun 25;4(7):101906. doi: 10.1016/j.jacadv.2025.101906.

Abstract

BACKGROUND

Heart failure with reduced ejection fraction (HFrEF) imposes high morbidity and mortality burdens. Outcomes improve significantly with guideline-directed medical therapy (GDMT), but patients infrequently achieve target regimens in practice.

OBJECTIVES

The purpose of this study was to determine the effectiveness of telehealth-delivered pharmacist comanagement for patients with HFrEF vs usual care to: 1) achieve goal GDMT therapy; and 2) reduce health care utilization.

METHODS

This nonrandomized controlled study, spanning 2022 to 2023, analyzed a health care delivery improvement project at an integrated health care network. In-network Medicare recipients with a HFrEF diagnosis (based on chart review) were divided into those covered by the network's risk-sharing agreement (intervention group) vs otherwise similar (comparison group) patients. A difference-in-difference analysis with inverse propensity weighting adjusted for observable risk factors. Intervention patients received medication reconciliation, new drug initiation, dose adjustments, and safety monitoring by program pharmacists via telehealth. Main outcome measures were hospitalizations and achievement of target GDMT therapy.

RESULTS

There were 190 intervention and 277 comparison group patients. The relative risk of cardiac hospitalization in the intervention group (vs comparison group) was 0.26 (95% CI: 0.08-0.86; P = 0.026), with an adjusted absolute risk reduction of 14.2 hospitalizations per 100 patient-years. In the intervention group, the ORs for achieving 3+ and 4 GDMT classes (vs comparison) were 2.73 (95% CI: 1.91-3.87; P < 0.001) and 2.27 (95% CI: 1.29-4.01; P = 0.005), respectively. The adjusted absolute increase in patients on 3+ and 4 GDMT classes were 23% and 21%, respectively.

CONCLUSIONS

A dedicated pharmacist comanagement telehealth program for patients with HFrEF proved effective at improving GDMT use and reducing cardiac hospitalizations.

摘要

背景

射血分数降低的心力衰竭(HFrEF)带来了高发病率和高死亡率负担。通过指南指导的药物治疗(GDMT),结局有显著改善,但在实际中患者很少能达到目标治疗方案。

目的

本研究的目的是确定远程医疗提供的药剂师共同管理对HFrEF患者的有效性,与常规治疗相比,以:1)实现目标GDMT治疗;2)减少医疗保健利用。

方法

这项非随机对照研究跨越2022年至2023年,分析了一个综合医疗保健网络中的医疗保健提供改进项目。根据图表审查诊断为HFrEF的网络内医疗保险接受者被分为受网络风险分担协议覆盖的患者(干预组)和其他类似患者(对照组)。采用倾向得分加权的差分分析来调整可观察到的风险因素。干预组患者通过远程医疗接受项目药剂师的用药核对、新药起始、剂量调整和安全性监测。主要结局指标是住院率和目标GDMT治疗的达成情况。

结果

干预组有190例患者,对照组有277例患者。干预组(与对照组相比)心脏住院的相对风险为0.26(95%CI:0.08 - 0.86;P = 0.026),调整后的绝对风险降低为每100患者年14.2次住院。在干预组中,达到3种及以上和4种GDMT类别的比值比(与对照组相比)分别为2.73(95%CI:1.91 - 3.87;P < 0.001)和2.27(95%CI:1.29 - 4.01;P = 0.005)。接受3种及以上和4种GDMT类别的患者调整后的绝对增加率分别为23%和21%。

结论

一项专门为HFrEF患者设计的药剂师共同管理远程医疗项目被证明在改善GDMT使用和减少心脏住院方面是有效的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6be1/12246936/4cfcafa5e520/ga1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验